24.79MMarket Cap
LossP/E TTM
Skye Bioscience Inc's Company Valuation
Currency: USD Updated: 2026-06-17The current valuation score of Skye Bioscience Inc is 6.90, ranking 285 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.49, which is -2284.95% below the recent high of 10.76 and -946.13% above the recent low of -5.15.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.